Kiora Pharmaceuticals (KPRX) Asset Utilization Ratio (2016 - 2025)

Kiora Pharmaceuticals' (KPRX) quarterly Asset Utilization Ratio came in at 0.43 in Q4 2024, up 5.77% on a QoQ basis from 0.4 in Q3 2024.

Kiora Pharmaceuticals (KPRX) Asset Utilization Ratio (2016 - 2025) Analysis & Trends

Kiora Pharmaceuticals (KPRX) has 7 years of Asset Utilization Ratio data on file, last reported at 0.43 in Q4 2024.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.43 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.43 (changed N/A YoY) and the FY2024 annual result came in at 0.64, changed N/A from the prior year.
Asset Utilization Ratio improved to 0.43 in Q4 2024, from 0.4 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q1 2024 to a low of 0.0 in Q2 2023.
A 3-year average of 0.22 and a median of 0.19 in 2020 frame the typical range for Asset Utilization Ratio.
Annual changes were most pronounced in 2020 — Asset Utilization Ratio plunged 99.65% — and 2024, when it soared 83087.75%.
Tracing KPRX's Asset Utilization Ratio over 3 years: stood at 0.0 in 2020, then slumped by 31.39% to 0.0 in 2023, then jumped by 63205.33% to 0.43 in 2024.
The last three Asset Utilization Ratio figures came in at 0.43 (Q4 2024), 0.4 (Q3 2024), and 0.38 (Q2 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.38
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	0.90
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	0.54
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.13
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	0.13
10	Kiora Pharmaceuticals	16.25 Mn	16.25 Mn	-	-

Download Data